Sarah Bos

133 General discussion 7 64. Potze W, Adelmeijer J, Lisman T. Decreased in vitro anticoagulant potency of Rivaroxaban and Apixaban in plasma from patients with cirrhosis. Hepatology. 2015 Apr;61(4):1435–6. 65. Bezinover D, Dirkmann D, Findlay J, Guta C, Hartmann M, Nicolau-Raducu R, et al. Perioperative coagulation management in liver transplant recipients. Transplantation. 2018;102(4):578–92. 66. Abuelkasem E, Hasan S, MazzeffiMA, Planinsic RM, Sakai T, Tanaka KA. Reduced Require- ment for Prothrombin Complex Concentrate for the Restoration of Thrombin Generation in Plasma From Liver Transplant Recipients. Anesth Analg. 2017;125(2):609–15. 67. Chavez-Tapia NC, Alfaro-Lara R, Tellez-Avila F, Barrientos-Gutiérrez T, González-Chon O, Mendez-Sanchez N, et al. Prophylactic activated recombinant factor VII in liver resection and liver transplantation: Systematic review and meta-analysis. PLoS One. 2011;6(7):1–7. 68. Bernal W, Caldwell SH, Lisman T. Nails in the coffin of fresh frozen plasma to prevent or treat bleeding in cirrhosis? J Hepatol. 2020;72(1):12–3. 69. Weeder PD, Porte RJ, Lisman T. Hemostasis in Liver Disease : Implications of New Concepts for Perioperative Management. Transfus Med Rev. 2014;28(3):107–13. 70. Massicotte L, Thibeault L, Roy A. Classical Notions of Coagulation Revisited in Relation with Blood Losses, Transfusion Rate for 700 Consecutive Liver Transplantations. Semin Thromb Hemost. 2015;41(05):538–46. 71. BiancofioreG, Blasi A, BoerMTDE, FranchiniM, HartmannM, LismanT, et al. Perioperative hemostatic management in the cirrhotic patient : a position paper on behalf of the Liver Intensive Care Group of Europe ( LICAGE ). Minerva Anesthesiol. 2019;85(July):782–98. 72. Rassi AB, D’Amico EA, Tripodi A, Rocha TRF da, Migita BY, Ferreira CM, et al. Fresh frozen plasma transfusion in patients with cirrhosis and coagulopathy: effect on conventional coagulation tests and thrombomodulin-modified thrombin generation. J Hepatol. 2019;72(1):85–94. 73. Tripodi A, Chantarangkul V, Primignani M, Mannucci PM. Thrombin generation in plasma from patients with cirrhosis supplemented with normal plasma: considerations on the efficacy of treatment with fresh-frozen plasma. 2012;139–44. 74. Stanworth SJ, Brunskill SJ, Hyde CJ, McClelland DBL, Murphy MF. Is fresh frozen plasma clinically effective? A systematic review of randomized controlled trials. Br J Haematol. 2004;126(1):139–52. 75. Bö H. Prothrombin Complex Concentrate Substitution during Liver Transplantation. Thromb Res. 1999;95:71–4. 76. Morrow GB, Beavis J, Harper S, Baker P, Desborough MJR, Curry N, et al. Coagulation status of critically ill patients with and without liver disease assessed using a novel thrombin generation analyzer. J Thromb Haemost. 2020;18(7):1576–85. 77. Wan J, Roberts LN, Hendrix W, Konings J, Ow TW, Rabinowich L, et al. Whole blood thrombin generation profiles of patients with cirrhosis explored with a near patient assay. J Thromb Haemost. 2020;18(4):834–43.